Home/Filings/5/0001140361-05-004306
5//SEC Filing

Futro Peter G 5

Accession 0001140361-05-004306

CIK 0001095963other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:46 PM ET

Size

24.4 KB

Accession

0001140361-05-004306

Insider Transaction Report

Form 5
Period: 2004-06-30
Futro Peter G
DirectorChm, Pres, CEO & Treasurer10% Owner
Transactions
  • Other

    Common Stock

    2003-11-03+270,000270,000 total(indirect: By Futro & Associates P.C.)
  • Other

    Common Stock

    2004-01-2980,0008,885,737 total(indirect: By Rangeley Corporation)
  • Other

    Common Stock

    2003-08-082,400,0008,885,737 total(indirect: By Rangeley Corporation)
  • Award

    Common Stock

    2003-11-03+560,000560,000 total
  • Other

    Common Stock

    2003-11-033,070,0008,885,737 total(indirect: By Rangeley Corporation)
  • Other

    Common Stock

    2004-04-0625,0008,885,737 total(indirect: By Rangeley Corporation)
  • Sale

    Common Stock

    2003-11-0381,0008,885,737 total(indirect: By Rangeley Corporation)
  • Sale

    Common Stock

    2004-01-29225,0008,885,737 total(indirect: By Rangeley Corporation)
  • Sale

    Common Stock

    2004-04-0663,6008,885,737 total(indirect: By Rangeley Corporation)
  • Other

    Common Stock

    2004-05-1841,0778,885,737 total(indirect: By Rangeley Corporation)
  • Sale

    Common Stock

    2004-05-18128,5868,885,737 total(indirect: By Rangeley Corporation)
Footnotes (11)
  • [F1]The Issuer issued 560,000 shares of restricted common stock to the Reporting Person as payment in full of accrued but unpaid salary of $140,000.
  • [F10]41,077 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third-parties in exchange for services valued at $1.75 per share.
  • [F11]128,586 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to third-parties for a cash amount of $1.75 per share.
  • [F2]The Issuer issued 270,000 shares of restricted common stock to the law firm of Futro & Associates, P.C., as payment in full of $67,562.38 due for legal services rendered. The Reporting Person is the principal of the law firm.
  • [F3]2,400,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third-parties in exchange for services valued at $.05 per share.
  • [F4]81,000 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to third parties for a cash amount of $.05 per share.
  • [F5]3,070,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third parties in exchange for services valued at $.25 per share.
  • [F6]225,000 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to third parties for a cash amount of $1.75 per share.
  • [F7]80,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to a third-party in settlement of a $80,000 debt.
  • [F8]63,600 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to third-parties for a cash amount of $1.75 per share.
  • [F9]25,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to a third-party in exchange for services valued at $1.75 per share.

Documents

1 file

Issuer

US MEDSYS CORP

CIK 0001095963

Entity typeother

Related Parties

1
  • filerCIK 0001295444

Filing Metadata

Form type
5
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:46 PM ET
Size
24.4 KB